White Papers

Inventory Management Agreements: Challenge in the Channel

Print page

Email page

Recent Inventory Management Agreements (IMAs) between drug manufacturers and wholesalers may have created unintended industry consequences such as increasing the risks and velocity of drug product shortages and imposing additional costs on as hospitals and pharmacies. In this white paper, Pembroke Consulting takes a critical look at the inventory impact of IMAs on companies such as Merck, Pfizer, BMS, and The Big Three drug wholesalers.

File Size: 249 KB
File Type: PDF

This content is for members only. Please use the login or register link below to access this white paper.

Login or Register Now